A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.
Neuro Oncol
; 23(10): 1777-1788, 2021 10 01.
Article
in En
| MEDLINE
| ID: mdl-33631016
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Neurofibromatosis 1
/
Optic Nerve Glioma
Limits:
Child
/
Humans
Language:
En
Journal:
Neuro Oncol
Journal subject:
NEOPLASIAS
/
NEUROLOGIA
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom